MAPT and Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia: Abnormal levels of total tau protein concentrations (tauopathies) in CSF have been identified as a potential therapeutic biomarker in several neurodegenerative disorders, including AD, PD, progressive supranuclear palsy and ALSP (14, 86–88).